Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Gen
Chief Executive Officer of Health Data Research UK Caroline Cake joins Patrick to talk about acceler
Kat Arney returns to the podcast to discuss her new book ‘Rebel Cell’, which takes an evolutionary l
This week we talk to Steff Di Pardo, a patient advocate and writer who has Ankylosing Spondylitis -
We talk to Peter about Nightingale Health's work with the UK Biobank, including recent research that
Sonya Abraham is a clinical senior lecturer in rheumatology and a research physician at Imperial Col
Tapoka Mkandawire is a PhD student in parasitology & genomics at the Wellcome Sanger Institute. She
Keith McArthur is one of the parents re-writing the rules for research in rare disease. Keith is CEO
Professor Sir Rory Collins, Founder and Chief Executive of the UK Biobank, talks to us this week abo
Andrea Ganna has been leading COVID19HG, a worldwide effort to understand the role that our genetics
Genomic data, is big data - so how do we actually make sense of this huge amount of data? And why sh
This episode covers some of the dramatic changes in the field of medical research as a result of COV
Why do some people have a severe response to COVID-19, and others seem to have no symptoms at all? I
This week we talk about COVID19 and what it’s really like to have the virus. Talking to Adelina Chal
What’s it like having a disease so rare, you’re misdiagnosed? Or you’re the only one in the whole of
How do you go from a cell to a baby? This question fixated Kat Arney at the beginning of her career,
Through combining genealogy with DNA testing, more can be discovered about family relationships - ma
In this week’s bonus episode we talk to Dr Angela Rasmussen (@angie_rasmussen), a Virologist at Colu
Today, Jillian Hastings Ward is a leader in the 100,000 genomes project, but she and her family star
Early detection for diseases like cancer is important to everyone, but Owlstone Medical is leading t
In this double-bill episode, Patrick talks to two key rare disease researchers in the field: Dr Bruc